Skip to main content
OpenTrials

Clinical trial condition

EGFR Mutation Positive Non-small Cell Lung Cancer

Explore clinical trials studying EGFR Mutation Positive Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

EGFR Mutation Positive Non-small Cell Lung Cancer trial results

Recruiting

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

NCT07315113

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Maryland Oncology Hematology Calverton, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions